Alcohol use after breast cancer doesn’t increase your
Support the Vail Breast Cancer Awareness Group on Colorado Gives Day!
Colorado’s largest one-day online giving event, presented by Community First Foundation and FirstBank, is coming up and we need your support.
On Tuesday, December 8, 2015, thousands of donors will come together to support Colorado nonprofits like ours. Last year, a record-breaking $26.2 million was raised for Colorado nonprofits, $772,541 of that was raised for nonprofits right here in Eagle County.
Check out our donation page on ColoradoGives.org:https://www.coloradogives.org/VailBreastCancerAwar…/overview.
Give where you live, give where you play on Colorado Gives Day. Your support helps us continue to provide financial and emotional assistance to those diagnosed with breast cancer in the vail valley. Beginning today, donations can be scheduled ahead of time. Thank you as always for the support in this beautiful community.
VIENNA—Acupuncture treatments appear to relieve the common
musculoskeletal discomfort experienced by women taking aromatase inhibitors (AIs) to reduce the risk of recurrent breast cancer, researchers reported in a small, single-arm study.
Giovanni Giardina, MD, Senior Assistant in Oncology at Ospedale diCircolo e Fondazione Macchi reported that a study of Italian women with self-reported musculoskeletal pain, who were treated with acupuncture techniques, reported improvement in pain and quality of life on validated assessment instruments.
He and his coauthors enrolled 17 women in the study, and reported on outcomes for 16, all of whom were experiencing musculoskeletal pain as a result of long-term therapy with aromatase inhibitors. The women ranged in age from 49 to 78, with a median of 62.
“All patients had a significant improvement of musculoskeletal aromatase inhibitor-related pain,” Giardina reported, “and our study suggests that acupuncture may be a promising modality for relieving aromatase inhibitor-related musculoskeletal side effects.
Warning that Hormone Replacement Therapy Nullifies Benefits of Exercise in Breast Cancer Risk-Reduction
BY ED SUSMAN
CHICAGO–Physical activity is known to reduce the risk of breast cancer–but all the benefit of that activity appears to be negated by taking hormone replacement therapy. That is the conclusion of a meta-analysis reported here at the American Society of Clinical Oncology Annual Meeting (Abstract 1561).
“If you are a runner you should not take hormone replacement therapy because the hormones appear to wipe out the benefit as far as prevention of breast cancer is concerned,” Cécile Pizot, MS, a biostatistician at the International Prevention Research Institute in France, said in an interview at her poster study.
“A lower risk of breast cancer among physically active women has been frequently reported, but the risk in women using hormone replacement therapy appears to be higher.”
Asked for her perspective, Stephanie Bernik, MD, Chief of Surgical Oncology at Lenox Hill Hospital in New York City, said: “Although it has been known that physical activity could reduce the risk of breast cancer and that hormone replacement could increase the risk of the disease, it is interesting that this meta-analysis showed that hormone replacement could actually negate the positive effects of exercise.
“Women who exercise often want to do what they can to feel young and stay healthy,” she continued. “Although we have known the negative effects of hormone therapy, doctors now have persuasive evidence that the negative effects of hormone replacement therapy override the positive effect of physical activity. Women should be encouraged to do what they can to live healthy lifestyles, with the understanding that it is difficult to justify the use of hormone replacement therapy as part of that equation.”
Memory problems and cognitive impairment in women with breast
cancer have traditionally been blamed on “chemo brain,” but a new
study shows that there may be problems even before patients start
on chemotherapy and suggests that cognitive problems may be
linked to cytokines released by the cancer.
The study was published online June 22 in the Journal of the National
The study is the first to describe a relationship between cytokines and
patients with newly diagnosed breast cancer who have not yet
received any cancer treatment.
“Cognitive dysfunction in breast cancer patients has traditionally been
attributed to the effects of chemotherapy (‘chemo brain’). However,
our findings indicate that it is present even prior to any cancer
treatment,” commented first author Sunita Patel, PhD, a clinical
neuropsychologist at City of Hope Medical Center, in Duarte,
In general, “chemo brain” refers to the side effects of chemotherapy,
whereas “cancer brain” includes cognitive problems related to many
factors involved in cancer, including stress, she explained.
“It may be helpful for patients who are fearful about cognitive side
effects of chemotherapy to know that new research suggests non-
treatment-related factors play a role,” Dr Patel added.
By The ASCO Post Posted: 7/17/2015
Methionine is abundant in meat, fish, some legumes, and nuts but low in fruits
A low-methionine diet that starves triple-negative breast cancer cells of an
essential nutrient primes the cancer cells to be more easily killed by a targeted
antibody treatment, according to a study published in Clinical Cancer Research.
The study’s senior author, Vincent Cryns, MD, Professor of Medicine at the
University of Wisconsin School of Medicine and Public Health, said the study lays
the foundation for a clinical trial to see whether a low-methionine diet will help
improve outcomes in women with triple-negative breast cancer.
Patients with triple-negative breast cancer have limited treatment options
because their tumor cells lack the three receptors—estrogen, progesterone, and
human epidermal growth factor receptor 2 (HER2)—commonly targeted in
hormone or chemotherapy.
Scientists have known for decades that methionine deficiency can block the
growth of many types of cancer, but the underlying mechanisms have puzzled
“We’ve shown that removing methionine can have a specific effect on a
molecular pathway that regulates cell death to increase the vulnerability of
cancer cells to treatments that target this pathway,” Dr. Cryns said. “What’s
particularly exciting about our findings is that they suggest that a dietary
intervention can increase the effectiveness of a targeted cancer therapy.”
This painting is dedicated to Breast Cancer Awareness. Her name is Pink (the essence of femininity). She is radiantly aware of her joyful grace, health, and beauty. Her gift is her everlasting presence with your donation of $3,600 to The Vail Breast Cancer Awareness Group.
Keep her in Bloom!
Contact: Vail Breast Cancer Awareness Group
email@example.com or 970.479.8595
THANK YOU to our wonderful community and everyone that has supported us over the last 20 years. Our 20th annual Celebration of Life Luncheon was a huge success and we couldn’t have done it without you! We appreciate you more than you know <3
A special thanks to our wonderful sponsors, some of whom have been with us since the beginning.
Vail Valley Medical Center/Shaw Regional Cancer Center
Ascent Sotheby’s International Realty
The Arrabelle Club
East West Partners/East West Resorts
The Golden Bear
Slifer Smith & Frampton
The Vail Daily
Vail Marriott Mountain Resort & Spa
Our 20th annual Celebration of Life Luncheon featuring Joy Behar is only 8 days away and we have some amazing silent auction items! To purchase tickets at $125 per person, email firstname.lastname@example.org or call 970.479.8595. To make pre-bids on these beautiful Silent Auction paintings please contact Joyce at jkbradley1
20×20 Watery Aspens
Retails for $2,000
18×18 Gold Leaf Fall
Retails for $1,700.